Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E)

Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E)

Introduction Current standard treatment for patients with early rectal cancer is radical surgical resection. Although radical surgery provides effective local tumour control, it also increases the mortality risk and considerable adverse effects, including bowel, bladder, sexual dysfunction and loss...

Full description

Bibliographic Details
Main Authors: Yan Wang, Hui Zhang, Sanjun Cai, Lijun Shen, Wang Yang, Zhen Zhang, Ruiyan Wu, Fan Xia, Shujuan Zhou, Xinxiang Li, Yaqi Wang, Yajie Chen, Juefeng Wan, Menglong Zhou
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/10/e076048.full

Internet

https://bmjopen.bmj.com/content/13/10/e076048.full

Similar Items